Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Mutation research

• Publication date

  2001-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0027-5107(01)00205-6PMID 11535244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity.

  2003cited by this paper
• Occurrence of CYP2D6 gene duplication in Hong Kong Chinese.

  2000cited by this paper
• CYP1A1 polymorphisms and lung cancer risk: a meta-analysis.

  2000cited by this paper
• CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10.

  2000cited by this paper
• The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.

  2000cited by this paper
• Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

  2000cited by this paper
• Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

  2000cited by this paper
• Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism.

  2000cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer.

  1999cited by this paper
• Duplication, multiduplication, and amplification of genes encoding drug-metabolizing enzymes: evolutionary, toxicological, and clinical pharmacological aspects.

  1999cited by this paper
• Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.

  1999cited by this paper
• Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.

  1999cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer

  1999cited by this paper
• Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.

  1999cited by this paper
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

  1999cited by this paper
• Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.

  1999cited by this paper
• Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.

  1999cited by this paper
• Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice.

  1999cited by this paper
• Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine.

  1999cited by this paper
• 10‐hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes

  1998cited by this paper
• Getting the right drug into the right patient

  1998cited by this paper
• Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

  1998cited by this paper
• Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.

  1998cited by this paper
• Nicotine metabolism defect reduces smoking

  1998cited by this paper
• Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians.

  1997cited by this paper
• Getting the right drug into the right patient

  1997cited by this paper
• A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.

  1997cited by this paper
• Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in luman beings

  1989cited by this paper

• ProPE expands the prime editing window and enhances gene editing efficiency where prime editing is inefficient

  2025cites this paper
• Gene network analysis reveals the responsive cascades of scallop (Patinopecten yessoensis) exposed to toxic Alexandrium catenella.

  2025cites this paper
• Personalized Medicine Approach to Proteomics and Metabolomics of Cytochrome P450 Enzymes: A Narrative Review

  2024cites this paper
• Ginkgo biloba Extract Safety: Insights from a Real-world Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) Events.

  2024cites this paper
• Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns

  2023cites this paper
• Establishing a cell-based screening workflow for determining the efficiency of CYP2C9 metabolism: moving towards the use of breath volatiles in personalised medicine

  2023cites this paper
• Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System

  2022cites this paper
• Toxicogenetics—Pharmacogenetics: Genetic variability profiling for xenobiotic response heterogeneity

  2021cites this paper
• Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease.

  2021cites this paper
• Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications

  2021cites this paper
• Emerging investigator series: human CYP2A6 catalyzes the oxidation of 6:2 fluorotelomer alcohol.

  2021cites this paper
• Role of Glutathione S-transferase (GSTM1, GSTT1) and CYP1A1 (cytochrome p450) Gene Polymorphisms in Susceptibility to Acute Myeloid Leukemia

  2020cites this paper
• ORAL LICHEN PLANUS-CURRENT POINT OF VIEW

  2020cites this paper
• Sensitive Humans Versus Average Persons in Toxicology

  2020cites this paper
• Polymorphisms of CYP1A1*4 and GST as Susceptibility and Prognostic Genes for Acute Myeloid Leukemia

  2020cites this paper
• Investigating Induced Pluripotent Stem Cells for Tissue Engineering and Hepatotoxicity Applications

  2019cites this paper
• The Molecular and Enzyme Kinetic Basis for Altered Activity of Three Cytochrome P450 2C19 Variants Found in Chinese Population.

  2019cites this paper
• Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing

  2019cites this paper
• Association of Cytochrome P450 2 E1 (C1053T) and NADPH Quinone Oxide Reducatase 1(C609T) (C 465T) Genes Polymorphism with Acute Lymphoblastic Leukemia in Sudanese Patients

  2019cites this paper
• Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization

  2018cites this paper
• Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies

  2018cites this paper
• ReviewArticle Evidence-Based Prevention ( EBP ) : A Revievv of Cytochrome P 450 Expression in the Bronchial Epithelium and New Approach to Lung Cancer Prevention "

  2018cites this paper
• Big Data in Computational Toxicology: Challenges and Opportunities

  2018cites this paper
• 3 Pharmacogenetics and Metabolism : Past , Present and Future

  2017cites this paper
• ROS Role of Cytochrome P 450 and Oxidative Stress in Alcohol-Induced Liver Injury

  2017cites this paper
• Antioxidant and Quinone Reductase Activity of Soyasaponins in Hepa1c1c7 Mouse Hepatocarcinoma Cells

  2017cites this paper
• Cytochrome P450 and Oxidative Stress in the Liver

  2017cites this paper
• Cytochrome P450 expression system for high-throughput real-time detection of genotoxicity: Application to the study of human CYP1A2 variants.

  2016cites this paper
• Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.

  2016cites this paper
• Opioid Receptor Agonists and Antagonists

  2016cites this paper
• Functional characterization of genetic polymorphisms in the organic cation transporter OCT1 with a special focus on the substrate-specific effects of the M420del polymorphism

  2016cites this paper
• Cytochrome P 450 2 E 1 RsaI / PstI polymorphism is associated with urologic cancer risk : evidence from a meta-analysis

  2015cites this paper
• Detection of CYP2C18 m1, and m2 Alleles within an Iranian Population (Mazandaran) Using Denaturing High-Performance Liquid Chromatography (DHPLC)

  2015influential citation
• Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

  2015cites this paper
• Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk

  2015cites this paper
• Pharmacogenetics: an Emerging Therapeutic Option for Bangladesh

  2015cites this paper
• Approaches and perspectives to toxicogenetics and toxicogenomics

  2015cites this paper
• Pharmacogenetic prediction of individual variability in drug response based on CYP2D6, CYP2C9 and CYP2C19 genetic polymorphisms.

  2015cites this paper
• Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.

  2015cites this paper
• Genomics and Oral Health: An Overview

  2014cites this paper
• Molecular mechanisms of the microsomal mixed function oxidases and biological and pathological implications

  2014cites this paper
• Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt

  2014cites this paper
• Extraordinarily Fast Response to Low-Dose Sertraline in a Child with Severe Obsessive-Compulsive Disorder and High Functioning Serotonin Transporter Genotype

  2014cites this paper
• Genetics Polymorphism of CYP3A4 Gene in Bladder Cancer Patients

  2014cites this paper
• Molecular Toxicology: Recombinant DNA Technology

  2014cites this paper
• Noninvasive Early Markers in Lung Cancer

  2014cites this paper
• Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes

  2014cites this paper
• Analysis of exhaled breath for disease detection.

  2014cites this paper
• The modulating effects of endogenous substances on drug metabolising enzymes and implications for inter-individual variability and quantitative prediction.

  2014cites this paper
• The gut-liver axis

  2013cites this paper
• Conformational diversity and ligand tunnels of mammalian cytochrome P450s

  2013cites this paper
• Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population

  2013cites this paper
• Risk of cancer after coal tar treatment

  2013cites this paper
• Introduction to Biochemical Pharmacology and Drug Discovery

  2013cites this paper
• ADVANCES IN PERSONALIZED MEDICINE: Pharmacogenetics in Drug Therapy

  2013cites this paper
• Topics on Drug Metabolism

  2012cites this paper
• Gene, ethnic and gender influences predisposition of adverse drug reactions to artesunate among Malaysians

  2012cites this paper
• Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking

  2012cites this paper
• Pharmacogenetics and Metabolism: Past, Present and Future

  2012cites this paper
• Individual response to drug therapy: bases and study approaches.

  2012cites this paper
• Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes

  2012cites this paper
• Cytochrom P450 1A1(Genotypisierung) [Biomonitoring Methods in German language, 2004]

  2012cites this paper
• Idiosyncratic Drug Reactions

  2012cites this paper
• Cytochrome P450 1A1 (genotyping) [Biomonitoring Methods, 2004]

  2012cites this paper
• CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

  2012cites this paper
• Clinical Pharmacology in Drug Labeling. The Impact of Drug Metabolism and Clinical Pharmacology on Recommended Dose of Drugs

  2012cites this paper
• Association of CYP3A5*3 polymorphism with development of acute leukemia

  2011cites this paper
• Predicting Drug Hypersensitivity Reactions: Mechanistic and Clinical Implications

  2011cites this paper
• Overview of Genomics and Gastrointestinal Health and Disease

  2011cites this paper
• Curso de Pós-Graduação em Biotecnologia em Saúde e Medicina Investigativa

  2011cites this paper
• Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients

  2011cites this paper
• Genetic influence on enantiomeric drug disposition : Focus on venlafaxine and citalopram

  2011cites this paper
• Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression

  2010cites this paper
• Polymorphisms of CYP 1 A 1 * 4 and GST as Susceptibility and Prognostic Genes for Acute Myeloid Leukemia

  2010cites this paper
• An innovative software solution for personalized pharmacotherapy.

  2010cites this paper
• Development of a semi-automated covalent binding methodology

  2010cites this paper
• Chemically Induced Allergy and Autoimmunity

  2010cites this paper
• Predictive Value of the Lymphocyte Toxicity Assay in the Diagnosis of Drug Hypersensitivity Syndrome

  2010cites this paper
• CYP1A1, GSTM1 and GSTT1 genetic polymorphism in Egyptian chronic myeloid leukemia patients.

  2010cites this paper
• Interactive effect of cigarette smoking and gene variants for predisposing to cardiovascular disease.

  2010cites this paper
• Genes de reparo do DNA e de susceptibilidade genética em pacientes com melanoma maligno

  2010cites this paper
• Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children

  2009cites this paper
• Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies

  2009cites this paper
• Biomarkers and drug development 2009.

  2009influential citation
• Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population

  2009cites this paper
• Challenges of genetic diversity and the use of high throughput genotyping in genetic epidemiology

  2009influential citation
• Haplotype Analysis and Single Nucleotide Polymorphism Frequency of PEPT1 Gene (Exon 5 and 16) in Korean

  2009cites this paper
• Molecular mechanisms involved in genotoxicity of industrially important monomers (styrene, 1,3-butadiene)

  2009cites this paper
• Polimorfismos genéticos no câncer de cabeça e pescoço: análise de risco e evolução clínica

  2008cites this paper
• „Therapeutic drug monitoring“ in Epileptologie und Psychiatrie

  2008cites this paper
• Implicações do polimorfismo genético de cyp1a1, gstm1 e gstt1 na suscetibilidade do carcinoma espinocelular da laringe

  2008cites this paper
• Evaluation of in vitro models for detection of hepatocyte toxicity induced by anti-cancer drugs

  2008cites this paper
• Automation of Sample Dispensing Using Pocket Tips for Evaluation of CYP2C9 Isoenzyme Reversible Inhibition in an Evolution Precision Pipetting Platform

  2008influential citation
• Molecular genetics of lung and pleural neoplasms

  2008cites this paper
• Cytochrome P450: another player in the myocardial infarction game?

  2007cites this paper
• The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.

  2007cites this paper
• Biomarkers in breast cancer Part II: protein, DNA, cell adhesion and drug resistance markers

  2007cites this paper
• Repair competence assay in studies of the influence of environmental exposure to c-PAHs on individual susceptibility to induction of DNA damage.

  2007cites this paper
• The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.

  2007cites this paper
• "Therapeutic drug monitoring" in Epileptologie und Psychiatrie

  2007cites this paper